Clinical Trials in Detroit

Showing 14021-14040 of 19,719 trials

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

NCT00048048

This study will evaluate the efficacy and safety of different subcutaneous starting doses and dosing frequencies of Mircera in anemic patients with chronic kidney disease not yet on dialysis. The anticipated time on study treatment is 3-12 months and the target sample size is \<100 individuals.

Anemia

Hoffmann-La Roche65 participantsStarted Mar 2002

Birmingham, Alabama, United States • San Diego, California, United States • Detroit, Michigan, United States +12 more locations

COMPLETEDPhase 2< 1 mile

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00895180

RATIONALE: Monoclonal antibodies, such as ramucirumab and anti-PDGFR alpha monoclonal antibody IMC-3G3 (Olaratumab), can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. PURPOSE: This phase II trial is studying how well ramucirumab or anti-PDGFR alpha monoclonal antibody IMC-3G3 works in treating patients with recurrent glioblastoma multiforme.

Adult Glioblastoma Multiforme

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins80 participantsStarted Jul 2010

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +8 more locations

A Study of Mircera in Anemic Patients With Chronic Kidney Disease Not Yet on Dialysis.

Ramucirumab or Anti-PDGFR Alpha Monoclonal Antibody IMC-3G3 in Treating Patients With Recurrent Glioblastoma Multiforme

Find Trials by Condition in Detroit

Trial to Evaluate Safety and Immunogenicity of INO-5150 Alone or With INO-9012 in Men With Prostate Cancer

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

KAVIAR Study - Kyphoplasty And Vertebroplasty In the Augmentation and Restoration of Vertebral Body Compression Fractures

InterStim Prospective Database

Prostatectomy Prospective Database

A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary Syndrome

Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers

Simvastatin Therapy for Moderate and Severe COPD

Study of the Safety of QRH-882260 Heptapeptide

Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Targeted Reinnervation as a Means to Treat Neuromas Associated With Major Limb Amputation

IMGN529 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia

Implementation of a Molecular Diagnostic for Pediatric Acute Gastroenteritis: The FilmArray GI Panel IMPACT Study

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Medication Adherence in Children Who Had a Liver Transplant

Condition of Approval Study